Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.63 USD | -2.23% | +4.78% | -19.45% |
Apr. 24 | Gain Therapeutics, Inc. Announces Positive Results from the Single Ascending Dose Part of the Phase 1 Clinical Trial of GT-02287 | CI |
Apr. 08 | Gain Therapeutics Names Gene Mack as CFO | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.45% | 47.48M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- GANX Stock
- News Gain Therapeutics, Inc.
- Earnings Flash (GANX) GAIN THERAPEUTICS Posts Q1 Revenue $55,180